Brintellix (Takeda Pharmaceuticals America, Inc.)
Welcome to the PulseAid listing for the Brintellix drug offered from Takeda Pharmaceuticals America, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Takeda Pharmaceuticals America, Inc. |
| NON-PROPRIETARY NAME: | vortioxetine |
| SUBSTANCE NAME: | VORTIOXETINE HYDROBROMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-10-02 |
| END MARKETING DATE: | 0000-00-00 |
Brintellix HUMAN PRESCRIPTION DRUG Details:
| Item Description | Brintellix from Takeda Pharmaceuticals America, Inc. |
| LABELER NAME: | Takeda Pharmaceuticals America, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2013-10-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 64764-550_cc70d6dd-e54b-483d-83f5-762a6cce455a |
| PRODUCT NDC: | 64764-550 |
| APPLICATION NUMBER: | NDA204447 |
Other VORTIOXETINE HYDROBROMIDE Pharmaceutical Manufacturers / Labelers:
